Pay in 4 interest-free payments of $6.87 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Steady-state plasma concentrations are typically achieved after approximately four to five weeks of weekly dosing
The primary outcome was change in the depression rating scale (MADRS)
Retatrutide is a peptide-based compound designed to target metabolic pathways, primarily used for research in metabolic disorders like obesity and insulin resistance
Your doctor may do tests to determine your risk of a serious heart event
US$ 28.29
US$ 25.93
US$ 26.31
